TY  - RPRT
TI  - An autologous cell-based therapeutic vaccine expressing IL6/1 fusokine drives robust anti-tumor response against ovarian cancer.
AU  - Sharma, S.
AU  - Das, R.
AU  - Pennati, A.
AU  - Hedican, C.
AU  - Barroilhet, L.
AU  - Patankar, M. S.
AU  - Galipeau, J.
PY  - 2026
DO  - 10.64898/2026.05.05.721149
UR  - https://www.biorxiv.org/content/10.64898/2026.05.05.721149v1
ID  - 10.64898/2026.05.05.721149
ER  -